Catalysts for Almatica Pharma LLC
44 tracked
Apr 2, 2026
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Feb 27, 2026
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 24, 2026
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Feb 18, 2026
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Feb 12, 2026
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Jan 14, 2026
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Jan 14, 2026
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Jan 7, 2026
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Jan 7, 2026
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Oct 29, 2025
recall
The Harvard Drug Group LLC recall (Cls II)
Almatica Pharma LLC
→
Oct 29, 2025
recall
The Harvard Drug Group LLC recall (Cls II)
Almatica Pharma LLC
→
Jul 9, 2025
recall
The Harvard Drug Group LLC recall (Cls II)
Almatica Pharma LLC
→
Mar 12, 2025
recall
Safecor Health, LLC recall (Cls II)
Almatica Pharma LLC
→
Dec 31, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Dec 31, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Dec 17, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Oct 15, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Oct 11, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Jul 8, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
May 29, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Apr 8, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Feb 26, 2024
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Nov 20, 2023
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Jul 17, 2023
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
May 12, 2023
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Apr 18, 2023
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Apr 18, 2023
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Apr 18, 2023
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→
Mar 31, 2022
approval
GABAPENTIN — FDA approval
Almatica Pharma LLC
→